RESUMO
Pancreatic adenocarcinoma is a highly aggressive cancer, with a median patient survival of less than one year. Clinically useful biomarkers capable of accurately assessing prognosis, as well as response to therapy, are urgently needed. At the 2014 ASCO Annual Meeting, Maus et al. (Abstract #e15199) and Neuzillet et al. (Abstract #e15200) present data on use of c-met as a prognostic biomarker, and Shultz et al. (Abstract #4133) use a multiplex antibody panel to identify predictive markers of response to gemcitabine and erlotinib.
Assuntos
Adenocarcinoma/metabolismo , Biomarcadores Tumorais/metabolismo , Neoplasias Pancreáticas/metabolismo , Adenocarcinoma/sangue , Adenocarcinoma/genética , Biomarcadores Tumorais/sangue , Biomarcadores Tumorais/genética , Antígeno Carcinoembrionário/sangue , Humanos , Subunidade alfa do Fator 1 Induzível por Hipóxia/sangue , Neoplasias Pancreáticas/sangue , Neoplasias Pancreáticas/genética , Prognóstico , Proteínas Proto-Oncogênicas c-met/genética , Proteínas Proto-Oncogênicas c-met/metabolismo , Análise de SobrevidaRESUMO
Tetraploidy can constitute a metastable intermediate between normal diploidy and oncogenic aneuploidy. Here, we show that the absence of p53 is not only permissive for the survival but also for multipolar asymmetric divisions of tetraploid cells, which lead to the generation of aneuploid cells with a near-to-diploid chromosome content. Multipolar mitoses (which reduce the tetraploid genome to a sub-tetraploid state) are more frequent when p53 is downregulated and the product of the Mos oncogene is upregulated. Mos inhibits the coalescence of supernumerary centrosomes that allow for normal bipolar mitoses of tetraploid cells. In the absence of p53, Mos knockdown prevents multipolar mitoses and exerts genome-stabilizing effects. These results elucidate the mechanisms through which asymmetric cell division drives chromosomal instability in tetraploid cells.
Assuntos
Carcinoma/metabolismo , Neoplasias do Colo/metabolismo , Genes mos , Mitose , Poliploidia , Proteína Supressora de Tumor p53/metabolismo , Aneuploidia , Animais , Carcinoma/genética , Linhagem Celular Tumoral , Centrossomo/metabolismo , Instabilidade Cromossômica , Neoplasias do Colo/genética , Feminino , Deleção de Genes , Regulação Neoplásica da Expressão Gênica , Humanos , Camundongos , Camundongos Nus , Proteína Supressora de Tumor p53/genéticaRESUMO
Tetraploidy may constitute a metastable state leading to numeric and structural chromosome abnormalities that are associated with cancer. Here, we show that cultured primary p53(-/-) (but not wild type, WT) mouse mammary epithelial cells (MMECs) accumulate a tetraploid sub-population in vitro. This occurs spontaneously, yet can be exacerbated by the addition of microtubule inhibitors as well as of inhibitors of cytokinesis. As compared to WT cells, tetraploid p53(-/-) MMECs contain supernumerary centrosomes and exhibit a reduced propensity to initiate the mitochondrial pathway of apoptosis. Moreover, tetraploid p53(-/-) MMECs are more resistant against anthracyclin-induced cell killing than their diploid counterparts. Altogether, these data indicate that p53 normally suppresses the generation of tetraploid cells, presumably by activating the intrinsic pathway of apoptosis. In the absence of p53, tetraploid cells accumulate as a result of inhibited apoptosis, which contributes to the acquisition of chemotherapy resistance.
Assuntos
Apoptose , Células Epiteliais/citologia , Células Epiteliais/metabolismo , Glândulas Mamárias Animais/citologia , Poliploidia , Proteína Supressora de Tumor p53/metabolismo , Animais , Morte Celular , Linhagem da Célula , Células Cultivadas , Centrossomo/metabolismo , Camundongos , Camundongos Endogâmicos C57BLRESUMO
Dying tumour cells can elicit a potent anticancer immune response by exposing the calreticulin (CRT)/ERp57 complex on the cell surface before the cells manifest any signs of apoptosis. Here, we enumerate elements of the pathway that mediates pre-apoptotic CRT/ERp57 exposure in response to several immunogenic anticancer agents. Early activation of the endoplasmic reticulum (ER)-sessile kinase PERK leads to phosphorylation of the translation initiation factor eIF2alpha, followed by partial activation of caspase-8 (but not caspase-3), caspase-8-mediated cleavage of the ER protein BAP31 and conformational activation of Bax and Bak. Finally, a pool of CRT that has transited the Golgi apparatus is secreted by SNARE-dependent exocytosis. Knock-in mutation of eIF2alpha (to make it non-phosphorylatable) or BAP31 (to render it uncleavable), depletion of PERK, caspase-8, BAP31, Bax, Bak or SNAREs abolished CRT/ERp57 exposure induced by anthracyclines, oxaliplatin and ultraviolet C light. Depletion of PERK, caspase-8 or SNAREs had no effect on cell death induced by anthracyclines, yet abolished the immunogenicity of cell death, which could be restored by absorbing recombinant CRT to the cell surface.
Assuntos
Antineoplásicos/farmacologia , Calreticulina/fisiologia , Morte Celular/imunologia , Retículo Endoplasmático/metabolismo , Antraciclinas/imunologia , Antraciclinas/farmacologia , Antineoplásicos/imunologia , Apoptose , Caspase 3/metabolismo , Caspase 8/metabolismo , Linhagem Celular , Fator de Iniciação 2 em Eucariotos/metabolismo , Exocitose , Complexo de Golgi/metabolismo , Humanos , Proteínas de Membrana/metabolismo , Compostos Organoplatínicos/imunologia , Compostos Organoplatínicos/farmacologia , Oxaliplatina , Fosforilação , Proteínas SNARE/metabolismo , Raios Ultravioleta , Proteína Killer-Antagonista Homóloga a bcl-2/metabolismo , Proteína X Associada a bcl-2/metabolismo , eIF-2 Quinase/metabolismoRESUMO
Physiological cell death, which occurs as a continuous byproduct of cellular turnover, is non-immunogenic or even tolerogenic, thereby avoiding autoimmunity. By contrast, cancer cell death elicited by radiotherapy and some chemotherapeutic agents such as anthracyclines is immunogenic. Recent data suggest that innate and cognate immune responses elicited by such anti-cancer agents are required for an optimal therapeutic outcome, underscoring the clinical relevance of immunogenic cell death. Here we discuss the concept that immunogenic death involves changes in the composition of the cell surface, as well as the release of soluble immunogenic signals that occur in a defined temporal sequence. This 'key' then operates on a series of receptors expressed by dendritic cells (DC, the 'lock') to allow for the presentation of tumor antigens to T cells and for the initiation of a productive immune response. Immunogenic cell death is characterized by the early cell surface exposure of chaperones including calreticulin and/or heat shock proteins, which determine the uptake of tumor antigens and/or affect DC maturation. Moreover, the late release of High mobility group box 1 (HMGB1), which acts on toll-like receptor 4 (TLR4), is required for optimal presentation of antigens from dying tumor cells. Nonetheless, numerous details on the molecular events that define immunogenicity remain to be defined, both at the level of the dying cancer cells and at the level of the responding innate effectors.
Assuntos
Antígenos de Neoplasias/imunologia , Apoptose/imunologia , Células Dendríticas/imunologia , Neoplasias/imunologia , Linfócitos T/imunologia , Receptor 4 Toll-Like/metabolismo , Animais , Antígenos de Neoplasias/metabolismo , Calreticulina/imunologia , Calreticulina/metabolismo , Células Dendríticas/metabolismo , Proteína HMGB1/imunologia , Proteína HMGB1/metabolismo , Proteínas de Choque Térmico/imunologia , Proteínas de Choque Térmico/metabolismo , Humanos , Ativação Linfocitária/imunologia , Camundongos , Neoplasias/patologia , Linfócitos T/metabolismo , Receptor 4 Toll-Like/imunologiaRESUMO
The mitochondrial protein apoptosis-inducing factor (AIF) translocates to the nucleus and induces apoptosis. Recent studies, however, have indicated the importance of AIF for survival in mitochondria. In the absence of a means to dissociate these two functions, the precise roles of AIF remain unclear. Here, we dissociate these dual roles using mitochondrially anchored AIF that cannot be released during apoptosis. Forebrain-specific AIF null (tel. AifDelta) mice have defective cortical development and reduced neuronal survival due to defects in mitochondrial respiration. Mitochondria in AIF deficient neurons are fragmented with aberrant cristae, indicating a novel role of AIF in controlling mitochondrial structure. While tel. AifDelta Apaf1(-/-) neurons remain sensitive to DNA damage, mitochondrially anchored AIF expression in these cells significantly enhanced survival. AIF mutants that cannot translocate into nucleus failed to induce cell death. These results indicate that the proapoptotic role of AIF can be uncoupled from its physiological function. Cell death induced by AIF is through its proapoptotic activity once it is translocated to the nucleus, not due to the loss of AIF from the mitochondria.
Assuntos
Fator de Indução de Apoptose/fisiologia , Apoptose , Mitocôndrias/fisiologia , Trifosfato de Adenosina/metabolismo , Animais , Fator de Indução de Apoptose/genética , Sobrevivência Celular , Células Cultivadas , Dano ao DNA , Potenciais da Membrana/fisiologia , Camundongos , Camundongos Knockout , Microscopia Eletrônica de Transmissão , Mitocôndrias/ultraestrutura , Membranas Mitocondriais/metabolismo , Membranas Mitocondriais/ultraestrutura , Neurônios/fisiologia , Neurônios/ultraestrutura , Consumo de Oxigênio , Prosencéfalo/embriologia , Prosencéfalo/metabolismo , Transporte ProteicoRESUMO
Apoptosis-inducing factor (AIF) is a mitochondrial flavoprotein that, after apoptosis induction, translocates to the nucleus where it participates in apoptotic chromatinolysis. Here, we show that human or mouse cells lacking AIF as a result of homologous recombination or small interfering RNA exhibit high lactate production and enhanced dependency on glycolytic ATP generation, due to severe reduction of respiratory chain complex I activity. Although AIF itself is not a part of complex I, AIF-deficient cells exhibit a reduced content of complex I and of its components, pointing to a role of AIF in the biogenesis and/or maintenance of this polyprotein complex. Harlequin mice with reduced AIF expression due to a retroviral insertion into the AIF gene also manifest a reduced oxidative phosphorylation (OXPHOS) in the retina and in the brain, correlating with reduced expression of complex I subunits, retinal degeneration, and neuronal defects. Altogether, these data point to a role of AIF in OXPHOS and emphasize the dual role of AIF in life and death.
Assuntos
Proteínas de Membrana/deficiência , Trifosfato de Adenosina/biossíntese , Animais , Apoptose , Fator de Indução de Apoptose , Encéfalo/metabolismo , Células Cultivadas , Complexo I de Transporte de Elétrons/biossíntese , Complexo III da Cadeia de Transporte de Elétrons/biossíntese , Flavoproteínas/genética , Flavoproteínas/metabolismo , Glucose/metabolismo , Humanos , Ácido Láctico/biossíntese , Proteínas de Membrana/genética , Proteínas de Membrana/metabolismo , Camundongos , Camundongos Transgênicos , Mitocôndrias/metabolismo , Miocárdio/metabolismo , Especificidade de Órgãos , Fosforilação Oxidativa , Filogenia , RNA Interferente Pequeno/metabolismo , Retina/metabolismo , Leveduras/genética , Leveduras/crescimento & desenvolvimento , Leveduras/metabolismoRESUMO
During the development of multicellular organisms, concerted actions of molecular signalling networks determine whether cells undergo proliferation, differentiation, death or ageing. Here we show that genetic inactivation of the stress signalling kinase, MKK7, a direct activator of JNKs in mice, results in embryonic lethality and impaired proliferation of hepatocytes. Beginning at passage 4-5, mkk7(-/-) mouse embryonic fibroblasts (MEFs) display impaired proliferation, premature senescence and G2/M cell cycle arrest. Similarly, loss of c-Jun or expression of a c-JunAA mutant in which the JNK phosphorylation sites were replaced with alanine results in a G2/M cell-cycle block. The G2/M cell-cycle kinase CDC2 was identified as a target for the MKK7-JNK-c-Jun pathway. These data show that the MKK7-JNK-c-Jun signalling pathway couples developmental and environmental cues to CDC2 expression, G2/M cell cycle progression and cellular senescence in fibroblasts.
Assuntos
Senescência Celular/genética , Fase G2/genética , Hepatócitos/enzimologia , Quinases de Proteína Quinase Ativadas por Mitógeno/deficiência , Mitose/genética , Estresse Fisiológico/enzimologia , Animais , Proteína Quinase CDC2/metabolismo , Proteínas de Ciclo Celular/genética , Proteínas de Ciclo Celular/metabolismo , Células Cultivadas , Feto , Fibroblastos/citologia , Fibroblastos/enzimologia , Genes Letais/genética , Hepatócitos/citologia , Proteínas Quinases JNK Ativadas por Mitógeno , Fígado/anormalidades , Fígado/patologia , MAP Quinase Quinase 7 , Sistema de Sinalização das MAP Quinases/genética , Camundongos , Quinases de Proteína Quinase Ativadas por Mitógeno/genética , Proteínas Quinases Ativadas por Mitógeno/metabolismo , Mutação/genética , Fosforilação , Proteínas Proto-Oncogênicas c-jun/deficiência , Proteínas Proto-Oncogênicas c-jun/genética , Estresse Fisiológico/genéticaRESUMO
Programmed cell death is used by multicellular organisms to eliminate excess, damaged or harmful cells. This process of cell suicide, defined in morphological terms as apoptosis, is crucial for developmental morphogenesis, tissue homeostasis and defense against pathogens. Over the past decade, our understanding of the genetic basis of the cell death machinery has grown exponentially using genetically modified organisms. In particular, inactivation of genes involved in cell death using homologous recombination in mice has provided an invaluable tool to understand the mechanisms, as well as the structural and functional consequences, of programmed cell death in mammals. This review discusses recent insights into the cellular death program as revealed by these mutant animals.
Assuntos
Apoptose/genética , Animais , Humanos , Camundongos , Camundongos Knockout , Neurônios/fisiologia , Receptores do Fator de Necrose Tumoral/fisiologia , Transdução de Sinais/fisiologiaRESUMO
Control and treatment of chronic pain remain major clinical challenges. Progress may be facilitated by a greater understanding of the mechanisms underlying pain processing. Here we show that the calcium-sensing protein DREAM is a transcriptional repressor involved in modulating pain. dream(-/-) mice displayed markedly reduced responses in models of acute thermal, mechanical, and visceral pain. dream(-/-) mice also exhibited reduced pain behaviors in models of chronic neuropathic and inflammatory pain. However, dream(-/-) mice showed no major defects in motor function or learning and memory. Mice lacking DREAM had elevated levels of prodynorphin mRNA and dynorphin A peptides in the spinal cord, and the reduction of pain behaviors in dream(-/-) mice was mediated through dynorphin-selective kappa (kappa)-opiate receptors. Thus, DREAM appears to be a critical transcriptional repressor in pain processing.